Navigation Links
Cholesterol-Lowering Statins Tied to Tendon Woes

But these side effects are rare and benefits still outweigh risks, experts say

FRIDAY, Feb. 29 (HealthDay News) -- Cholesterol-lowering statins could raise the risk for tendon problems, French researchers report.

However, "our series suggests that statin-attributed tendinous complications are rare, considering the huge number of statin prescriptions," wrote physicians at Rouen University Hospital.

Reporting in the March issue of Arthritis Care and Research, they drew on a national database of side effects reported in France between 1990 and 2005.

In those years, French doctors reported a total of 4,597 statin-related side effects. About 2 percent of those involved problems such as tendinitis or tendon tears, usually arising within eight months of beginning statin therapy. The year-by-year incidence of reported tendon side effects was small -- 13 of 446 statin-attributed side effects in 2003, 19 of 528 in 2004, and 11 of 421 in 2005.

But there have been other reports of unwanted side effects linked to statins, including an increased risk of brain hemorrhage in people taking the drugs after stroke. Most notably, one 2005 study found a higher incidence of muscle problems with Crestor, the newest and most powerful of the cholesterol-busting medications.

The problem with all such studies, including the new French survey, is that they depend on doctors' reporting side effects, said Dr. Richard Karas, director of the Preventive Cardiology Center and Women's Health Center at Tufts-New England Medical Center, who worked on the Crestor report.

"The proportion of events reported is small," Karas said. "If health-care providers don't consider a side effect to be a side effect, they don't report it."

However, the data reported by the French researchers agrees with that collected in the United States, Karas said. The risk for tendon trouble appears to hit men more often than women, he added. "There is a preponderance of men in both papers, about two to one," he noted.

"The importance of these findings is that they put the issue on the radar screen, so you can see if the risk is the same as in the general population," Karas said.

Another American study of statin side effects, about to be reported, finds that tendon problems are not common but do occur because the drugs impair the mitochondria, the energy-producing units of cells, said Dr. Beatrice Golomb, lead author of that study and an associate professor of medicine and of family and preventive medicine at the University of California at San Diego. This cellular impairment can also lead to muscle problems, she said.

It's impossible to give an overall number for incidence of the tendon problems linked to statin use because, "that depends on the dose of statins and the illness of the patient," Golomb said. "Older people with more medical problems tend to have more side effects."

"However you slice it, the tendon problems are less widely reported than muscle problems," she said.

Golomb and Karas differed on the importance of the adverse side effects of statins, which are among the most widely prescribed drugs in the world.

"I'm strongly in the camp that says there is overwhelming evidence that, overall, statins are safe and play an important role in our attempt to reduce heart attacks and stroke," Karas said. "The overall risk-benefit ratio is tilted strongly toward benefit."

But the balance of benefit over risk applies only "if you happen to be a middle-aged man with heart disease or at risk of heart disease," Golomb said. "For other groups, the risk outweighs the benefits."

More information

There's more on cholesterol-lowering medicines at the American Heart Association.

SOURCES: Richard Karas, M.D., director, Preventive Cardiology Center, Tufts-New England Medical Center, Boston; Beatrice Golomb, M.D., associate professor, medicine and family and preventive medicine, University of California, San Diego; March 2008 Arthritis Care and Research

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cholesterol-lowering drug linked to sleep disruptions
2. Many Patients Stop Taking Cholesterol-Lowering Drugs
3. New Type of Cholesterol-Lowering Drug Shows Promise
4. Cholesterol-Lowering Drugs May Ease Irregular Heartbeat
5. Stopping Statins After Stroke Doubles Death Risk
6. Research to shed new light on how statins benefit heart patients
7. Statins reduce loss of function, keeping old lungs young - even in smokers
8. Better Prostate Cancer Survival for Men Taking Statins
9. Statins After Bypass Lower Stroke Risk
10. Latest Study Says Statins Dont Slow Alzheimers
11. New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment
Post Your Comments:
Related Image:
Cholesterol-Lowering Statins Tied to Tendon Woes
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: